Aug 2026· Atherosclerosis· Vol 421, pp.
121880
· 0 citations· 14 references
Medicine
TL;DR
Conventional apoB substantially underestimated weighted atherogenic burden in individuals with elevated Lp(a), with discordance increasing at higher concentrations, and particle-specific weighting approaches for apoB-based cardiovascular risk assessment are supported.
Abstract
Background
AND
Aims
Apolipoprotein B (apoB) is the preferred marker of atherogenic particle burden, but it assumes that all apoB-containing lipoproteins confer the same cardiovascular risk. Mendelian randomization studies suggest that triglyceride-rich lipoproteins (TRLs) and lipoprotein(a) [Lp(a)] are more atherogenic per apoB particle than LDL. Risk-weighted apoB (RW-apoB) captures these differences in a single metric. We assessed the reclassification produced by RW-apoB versus measured apoB in the GAELp(a) registry, a real-world Lp(a)-enriched cohort.
Methods
This post-hoc analysis of the GAELp(a) registry included 1861 adults with available apoB, Lp(a) expressed in nmol/L, and fasting triglycerides (TG) < 250 mg/dL. RW-apoB was calculated as: 11.65 × TG (mmol/L) + 0.215 × Lp(a) (nmol/L) + 0.736 × apoB (mg/dL). Reclassification was defined as the change in percentile rank between RW-apoB and measured apoB (Δ percentile). Analyses were stratified across five Lp(a) categories. A complementary analysis without TG truncation was performed in 1966 participants to evaluate the contribution of each RW-apoB component.
Results
Mean apoB was 89.9 ± 27.6 mg/dL, whereas mean RW-apoB was 103.7 ± 36.3 mg/dL. Overall, 60.0% of participants were reclassified by ≥ 10 percentile points. In individuals with Lp(a) < 75 nmol/L, measured apoB slightly overestimated weighted atherogenic burden (median Δ percentile: -13.2). Conversely, apoB progressively underestimated weighted atherogenic burden with increasing Lp(a), reaching an RW-apoB/apoB ratio of 1.91 and median Δ percentile of +34.7 at Lp(a) ≥300 nmol/L. The reclassification pattern was virtually identical in the no-truncation analysis (60.0%), with Lp(a)-not TRL-identified as the primary driver of discordance between RW-apoB and measured apoB.
Conclusions
Conventional apoB substantially underestimated weighted atherogenic burden in individuals with elevated Lp(a), with discordance increasing at higher concentrations. These findings support particle-specific weighting approaches for apoB-based cardiovascular risk assessment.
Low-density lipoprotein cholesterol (LDL-C) remains the primary target for cardiovascular risk reduction; however, it reflects cholesterol content rather than the total number of circulating atherogenic particles. Apolipoprotein B (ApoB), present in one copy per atherogenic lipoprotein particle, more directly rep...
M. Bezerra, Alice Petrola Bezerra Sayao, Rachel Petrola et al.· Clinical Chemistry· 0 citations
Differentiating Lp(a)-associated from non-Lp(a)-associated apoB particle pools provides complementary information on coronary plaque phenotype, and the non-Lp(a) apoB/Lp(a) ratio summarizes their relative predominance.
S. Tsimikas, J. Januzzi, Michael Maeng et al.· European Journal of Preventi...· 0 citations
Acute coronary syndrome (ACS) is a critical clinical emergency resulting from the rupture or erosion of coronary atherosclerotic plaques and subsequent thrombosis. Its pathogenesis is driven by a complex interplay of dysregulated lipid metabolism, inflammatory responses, thrombotic processes, and genetic susceptibility...
Zu-Qiang Lu, Pan-Kui Li, Rui-Rui Li et al.· Frontiers in Cardiovascular...· 0 citations
Apolipoprotein B (ApoB) serves as the structural backbone of triglyceride (TG)-rich lipoproteins and low-density lipoprotein (LDL) particles and plays a key role in lipid transport. A growing body of evidence indicates that circulating ApoB levels are closely associated with the development of cardiovascular diseases s...
Ling-Ling Li, Yi-Xuan Feng, Xiao-Ya Li et al.· Frontiers in Cardiovascular...· 0 citations
Background Circulating apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) have been proposed as vital biomarkers in the pathological process of coronary heart disease (CAD). However, their associations with novel cardiometabolic indices [triglyceride glucose body mass index (TyG-BMI), atherogenic index of plasma (AI...
Ping Hu, Nan Lu, Jie Wang et al.· Frontiers in Cardiovascular...· 0 citations
Findings suggest multiple assessments may be warranted for Lp(a)-related risk stratification and, potentially, eligibility for Lp(a)-targeted treatments, particularly among individuals with relatively high concentrations or certain demographic and clinical characteristics.
M. Szarek, Deepak L. Bhatt, Michael Miller et al.· Journal of Clinical Lipidolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.